ARTICLES
Designing adherence programs: Local is better than global
Angelo DePalma, Aug 23, 2010
Kenneth Youngstein, CEO of Biocom, on the regulatory, strategic, and tactical challenges of cross-border compliance programs.
Compliance and the corporate brand
Di Stafford, Aug 23, 2010
Di Stafford explores role pharma corporate brands can play in medicine adherence.
The role of new technologies in enhancing compliance
Peter Mansell, Jul 27, 2010
Peter Mansell reports on how compliance and personal monitoring technologies can help pharma firms better tailor their offerings to different patient groups
Q&A: The role of the caregiver in brand loyalty and compliance
Andrew Tolve, Jul 27, 2010
Rebecca Joslin, brand associate director for Novartis’ Exelon Patch, on how reaching out to caregivers creates brand loyalty and improves adherence
Compliance and the older patient: How the Web can help
Di Stafford, Jul 27, 2010
Di Stafford explains how customized digital communication can assist pharma in successfully engaging with older patients
Adherence and the empowered patient
Peter Mansell, Jun 28, 2010
Peter Mansell explains how patient access to new technologies and new data could impact everything from compliance to cost-benefit analyses.
The pharmacist's role in patient adherence
Les Rose, Jun 28, 2010
Ema Paulino, a member of the board of the Italian National Association of Pharmacies, talks to eyeforpharma about the role of the pharmacist and technology in improving patient compliance.
Compliance and social marketing: a new opportunity for collaboration
Di Stafford, Jun 28, 2010
Di Stafford explains why social marketing, rather than social media, may offer the best prospects for improving adherence.
BLOGS
Learning to take our medicine
Malcolm Allison, Aug 23, 2010
Why a little dose of fear is good for compliance.
Mal’s Musings: It’s time for pharma to get serious about CSR
'Mal Barnard', Jul 26, 2010
Why future success should be measured by gains in corporate social responsibility (CSR) as well as in share price
Southwest Airlines and Pharma Content Creation: What’s the Connection?
Sam Agris, Jul 08, 2010
I spend a fair amount of time on airplanes for business and some for pleasure and always try to take the nonstop flight to my destination.
What consumers want in DTC ads
Richard Meyer, Jul 06, 2010
A group of consumer, senior, patient safety organizations and small insurers, including Community Catalyst and various state public interest research groups, filed their own comments with the FDA o
Mal’s Musings: Segmentation, Segmentation, Segmentation
'Mal Barnard', Jun 21, 2010
Customers differ! They differ in characteristics, needs, and the way they respond to our value propositions.
Digital spend: the chicken or the egg?
fschenck, May 28, 2010
Quantifying industry e-spend
“How much of our sales and marketing spend should go to digital?” That’s a question we often get. 5%? 10%? More? Less?
The three account selling disciplines
Torsten v. Bernewitz, May 26, 2010
Ask five pharma companies what KAM is and you may get three to five different answers.Ask a consultant and the answer is probably “it depends”.
And they are probably all right.
Mal’s Musings: Is Value-based Selling (VBS) Just Plain BS?
'Mal Barnard', Apr 27, 2010
For decades, most business enthusiasts have propagated the relationship between value and customers. Yet we find ourselves constantly being challenged about the value we deliver.
User login
Events
Patient Adherence & Engagement USA
October 19-20, 2010 - Philadelphia - Click here
19/10/2010 - 16:50
20/10/2010 - 16:50
Etc/GMT
Patient Adherence & Engagement USA 2010
Key Account Management Europe
November 29-30, 2010 - London - Click here